DK1725258T3 - Kombinationsvacciner med lav dosis Hib-konjugat - Google Patents
Kombinationsvacciner med lav dosis Hib-konjugatInfo
- Publication number
- DK1725258T3 DK1725258T3 DK05727218.9T DK05727218T DK1725258T3 DK 1725258 T3 DK1725258 T3 DK 1725258T3 DK 05727218 T DK05727218 T DK 05727218T DK 1725258 T3 DK1725258 T3 DK 1725258T3
- Authority
- DK
- Denmark
- Prior art keywords
- hib
- combination vaccines
- low dose
- dose combination
- hib conjugate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Steroid Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0405787.3A GB0405787D0 (en) | 2004-03-15 | 2004-03-15 | Low dose vaccines |
PCT/IB2005/000927 WO2005089794A2 (en) | 2004-03-15 | 2005-03-14 | Combination vaccines with low dose of hib conjugate |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1725258T3 true DK1725258T3 (da) | 2010-11-01 |
Family
ID=32117706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK05727218.9T DK1725258T3 (da) | 2004-03-15 | 2005-03-14 | Kombinationsvacciner med lav dosis Hib-konjugat |
Country Status (13)
Country | Link |
---|---|
US (2) | US20090208526A1 (da) |
EP (1) | EP1725258B1 (da) |
JP (2) | JP4954056B2 (da) |
CN (2) | CN1968711B (da) |
AT (1) | ATE480257T1 (da) |
BR (1) | BRPI0508813B8 (da) |
CA (1) | CA2559996C (da) |
DE (1) | DE602005023422D1 (da) |
DK (1) | DK1725258T3 (da) |
GB (1) | GB0405787D0 (da) |
RU (1) | RU2435609C2 (da) |
SG (1) | SG151253A1 (da) |
WO (1) | WO2005089794A2 (da) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4870895B2 (ja) * | 2000-06-29 | 2012-02-08 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン組成物 |
GB0505518D0 (en) * | 2005-03-17 | 2005-04-27 | Chiron Srl | Combination vaccines with whole cell pertussis antigen |
US8329184B2 (en) | 2005-06-27 | 2012-12-11 | Glaxosmithkline Biologicals S.A. | Process for manufacturing vaccines |
EA016417B1 (ru) | 2006-09-07 | 2012-04-30 | Глаксосмитклайн Байолоджикалс С.А. | Способ получения вакцины |
GB0700135D0 (en) * | 2007-01-04 | 2007-02-14 | Glaxosmithkline Biolog Sa | Vaccine |
AU2008259423A1 (en) * | 2007-06-04 | 2008-12-11 | Novartis Ag | Formulation of meningitis vaccines |
CU23652A1 (es) * | 2007-06-29 | 2011-05-27 | Centro Inmunologia Molecular | Composición vacunal homogénea para el tratamiento del cáncer y su método de obtención |
CA2726824A1 (en) | 2008-05-01 | 2009-11-05 | Arecor Limited | Protein formulation |
PE20100366A1 (es) * | 2008-10-24 | 2010-05-21 | Panacea Biotec Ltd | Novedosas composiciones de vacuna con tos ferina acelular asi como el metodo para su elaboracion |
PE20100365A1 (es) | 2008-10-24 | 2010-05-21 | Panacea Biotec Ltd | Novedosas vacunas de combinacion con tos ferina de celulas enteras y metodo para su elaboracion |
GB0822633D0 (en) * | 2008-12-11 | 2009-01-21 | Novartis Ag | Formulation |
MX2012002723A (es) | 2009-09-02 | 2012-04-11 | Novartis Ag | Composiciones inmunogenicas que incluyen moduladores de la actividad de receptores tipo toll. |
CN102655879B (zh) * | 2009-12-16 | 2016-03-09 | 印度血清研究所 | 疫苗组合物 |
US20120177681A1 (en) | 2010-09-01 | 2012-07-12 | Manmohan Singh | Formulation of immunopotentiators |
RU2013144207A (ru) | 2011-03-02 | 2015-04-10 | Новартис Аг | Комбинированные вакцины с пониженными дозами антигена и/или адъюванта |
EP2699266B1 (en) * | 2011-04-21 | 2019-06-12 | Trustees Of Tufts College | Compositions and methods for stabilization of active agents |
JP6345603B2 (ja) | 2012-03-08 | 2018-06-20 | ノバルティス アーゲー | 追加免疫ワクチンのアジュバント化された処方物 |
KR102144602B1 (ko) * | 2012-10-29 | 2020-08-13 | 더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 | 새로운 점막 보조제 및 전달 시스템 |
RU2626532C2 (ru) * | 2015-01-16 | 2017-07-28 | Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Министерства здравоохранения Российской Федерации | Комбинированная вакцина для профилактики коклюша, дифтерии, столбняка, гепатита в и инфекции, вызываемой haemophilus influenzae тип в |
WO2018074296A1 (ja) * | 2016-10-20 | 2018-04-26 | 一般財団法人化学及血清療法研究所 | 低分子化PRPを用いたHibコンジュゲートワクチンの製造方法 |
EA202090316A1 (ru) | 2017-07-18 | 2020-12-08 | Серум Инститьют Оф Индия Пвт Лтд. | Иммуногенная композиция с повышенной стабильностью, усиленной иммуногенностью и уменьшенной реактогенностью и способ ее получения |
CN110251667A (zh) * | 2018-05-11 | 2019-09-20 | 武汉博沃生物科技有限公司 | 一种免疫组合制剂及其制备方法和应用 |
JOP20190242A1 (ar) | 2018-10-12 | 2020-04-12 | Serum Institute Of India Pvt Ltd | تركيبة لقاح توليفي تشمل فيروس شلل الأطفال ذو جرعة مخفّضة خاملة التنشيط وطريقة لتحضيرها |
WO2021176409A1 (en) | 2020-03-05 | 2021-09-10 | Sanofi Healthcare India Private Limited | Preservative combination for vaccine composition |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2734484B1 (fr) * | 1995-05-24 | 1997-06-27 | Pasteur Merieux Serums Vacc | Composition vaccinale liquide et procede de fabrication |
US20020054884A1 (en) * | 1995-06-23 | 2002-05-09 | Smithkline Beecham Biologicals, Sa | Vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate |
EP0833662B2 (en) * | 1995-06-23 | 2011-01-26 | SmithKline Beecham Biologicals S.A. | A vaccine composition comprsing a Haemophilus influenzae B polysaccharide conjugate antigen adsorbed onto aluminium phosphate |
JP4870895B2 (ja) * | 2000-06-29 | 2012-02-08 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン組成物 |
-
2004
- 2004-03-15 GB GBGB0405787.3A patent/GB0405787D0/en not_active Ceased
-
2005
- 2005-03-14 DE DE602005023422T patent/DE602005023422D1/de active Active
- 2005-03-14 JP JP2007503444A patent/JP4954056B2/ja not_active Expired - Fee Related
- 2005-03-14 DK DK05727218.9T patent/DK1725258T3/da active
- 2005-03-14 CN CN2005800152906A patent/CN1968711B/zh not_active Expired - Fee Related
- 2005-03-14 RU RU2006136212/15A patent/RU2435609C2/ru not_active IP Right Cessation
- 2005-03-14 US US10/593,007 patent/US20090208526A1/en not_active Abandoned
- 2005-03-14 CA CA2559996A patent/CA2559996C/en not_active Expired - Fee Related
- 2005-03-14 SG SG200901653-6A patent/SG151253A1/en unknown
- 2005-03-14 EP EP05727218A patent/EP1725258B1/en active Active
- 2005-03-14 AT AT05727218T patent/ATE480257T1/de not_active IP Right Cessation
- 2005-03-14 CN CN2010105870900A patent/CN102028944B/zh not_active Expired - Fee Related
- 2005-03-14 WO PCT/IB2005/000927 patent/WO2005089794A2/en active Application Filing
- 2005-03-14 BR BRPI0508813A patent/BRPI0508813B8/pt active IP Right Grant
-
2008
- 2008-03-06 JP JP2008056997A patent/JP2008150397A/ja active Pending
-
2011
- 2011-09-30 US US13/250,094 patent/US9259460B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP4954056B2 (ja) | 2012-06-13 |
CA2559996C (en) | 2014-08-05 |
US20090208526A1 (en) | 2009-08-20 |
RU2006136212A (ru) | 2008-04-27 |
CN1968711A (zh) | 2007-05-23 |
SG151253A1 (en) | 2009-04-30 |
WO2005089794A3 (en) | 2006-03-09 |
BRPI0508813B8 (pt) | 2021-05-25 |
ATE480257T1 (de) | 2010-09-15 |
DE602005023422D1 (de) | 2010-10-21 |
CN102028944B (zh) | 2013-12-04 |
EP1725258A2 (en) | 2006-11-29 |
CN102028944A (zh) | 2011-04-27 |
RU2435609C2 (ru) | 2011-12-10 |
GB0405787D0 (en) | 2004-04-21 |
BRPI0508813B1 (pt) | 2019-05-21 |
JP2007529503A (ja) | 2007-10-25 |
US9259460B2 (en) | 2016-02-16 |
CN1968711B (zh) | 2011-01-05 |
US20120107346A1 (en) | 2012-05-03 |
JP2008150397A (ja) | 2008-07-03 |
WO2005089794A2 (en) | 2005-09-29 |
CA2559996A1 (en) | 2005-09-29 |
EP1725258B1 (en) | 2010-09-08 |
BRPI0508813A (pt) | 2007-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1725258T3 (da) | Kombinationsvacciner med lav dosis Hib-konjugat | |
UY26801A1 (es) | Composición de vacuna | |
NZ598367A (en) | Multiple vaccination including serogroup C meningococcus | |
DK1835939T3 (da) | Meningokokkonjugatvaccination | |
NO20015073D0 (no) | Vaksiner | |
MA30065B1 (fr) | Vaccin | |
DK1740217T3 (da) | Meningokok-konjugat-vaccination | |
LU92262I2 (fr) | Vaccin méningococcique groupe B (ADNr, composant, adsorbé) et ses dérivés pharmaceutiquement acceptables (BEXSERO) | |
RU2009149359A (ru) | Состав вакцин против менингита | |
RU2009134033A (ru) | Жидкие вакцины для множественных серогрупп менингококков | |
AR066376A1 (es) | Vacuna | |
WO2006004390A3 (es) | Proceso para la preparación y uso de una vacuna bivalente contra la adicción a la morfina-heroína | |
WO2005007804A3 (en) | Anthrax conjugate vaccine and antibodies | |
FR2796282B1 (fr) | Vaccin inactive contre la calicivirose feline |